Federation des caisses Desjardins du Quebec Trims Position in DaVita Inc. $DVA

Key Points

• The Federation des caisses Desjardins du Quebec reduced its holdings in DaVita Inc. by 12.7%, owning 19,877 shares worth approximately $3,041,000 as of the latest SEC filing.
• Insider James O. Hearty sold 2,351 shares of DaVita stock for around $352,650, reducing his ownership by 8.28%.
• Analysts have a consensus rating of "Hold" for DaVita shares, with a target price of $164.00, while the company reported earnings that exceeded expectations at $2.95 per share.

Federation des caisses Desjardins du Quebec reduced its holdings in DaVita Inc. (NYSE:DVA - Free Report) by 12.7% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 19,877 shares of the company's stock after selling 2,886 shares during the quarter. Federation des caisses Desjardins du Quebec's holdings in DaVita were worth $3,041,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of the business. Iron Triangle Partners LP purchased a new position in shares of DaVita during the fourth quarter worth about $38,946,000. GAMMA Investing LLC lifted its position in DaVita by 14,695.8% during the first quarter. GAMMA Investing LLC now owns 234,809 shares of the company's stock valued at $35,919,000 after purchasing an additional 233,222 shares during the last quarter. Doma Perpetual Capital Management LLC grew its stake in DaVita by 172.3% in the 1st quarter. Doma Perpetual Capital Management LLC now owns 288,360 shares of the company's stock worth $44,110,000 after buying an additional 182,476 shares in the last quarter. Northern Trust Corp increased its holdings in shares of DaVita by 20.2% in the 1st quarter. Northern Trust Corp now owns 890,632 shares of the company's stock worth $136,240,000 after buying an additional 149,858 shares during the last quarter. Finally, Nuveen LLC purchased a new stake in shares of DaVita during the 1st quarter valued at $20,218,000. Institutional investors own 90.12% of the company's stock.

Insider Transactions at DaVita

In other DaVita news, insider James O. Hearty sold 2,351 shares of the business's stock in a transaction dated Wednesday, July 23rd. The shares were sold at an average price of $150.00, for a total value of $352,650.00. Following the transaction, the insider owned 26,038 shares in the company, valued at approximately $3,905,700. The trade was a 8.28% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.50% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on DVA shares. Bank of America cut their target price on shares of DaVita from $145.00 to $140.00 and set an "underperform" rating for the company in a research report on Wednesday. Truist Financial set a $148.00 price objective on DaVita in a report on Friday, August 8th. Barclays decreased their price objective on DaVita from $169.00 to $160.00 and set an "equal weight" rating on the stock in a report on Thursday, August 7th. Finally, Wall Street Zen raised DaVita from a "hold" rating to a "buy" rating in a research note on Friday, August 22nd. Three research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, DaVita currently has an average rating of "Reduce" and a consensus target price of $158.00.

DaVita Trading Up 0.8%

DVA stock traded up $1.06 during trading on Thursday, hitting $133.32. 728,851 shares of the company traded hands, compared to its average volume of 671,162. The company has a 50-day moving average of $138.64 and a 200-day moving average of $141.60. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.34 and a current ratio of 1.39. DaVita Inc. has a 1 year low of $126.07 and a 1 year high of $179.60. The firm has a market capitalization of $9.53 billion, a PE ratio of 13.11, a P/E/G ratio of 0.95 and a beta of 1.13.

DaVita (NYSE:DVA - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $2.95 earnings per share for the quarter, beating the consensus estimate of $2.70 by $0.25. DaVita had a return on equity of 369.39% and a net margin of 6.35%.The firm had revenue of $3.38 billion during the quarter, compared to the consensus estimate of $3.36 billion. During the same quarter in the previous year, the company posted $2.00 earnings per share. The business's revenue was up 6.1% on a year-over-year basis. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. Analysts predict that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.